A detailed history of Commonwealth Equity Services, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 23,613 shares of ETNB stock, worth $235,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,613
Previous 23,293 1.37%
Holding current value
$235,421
Previous $187,000 6.42%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$7.36 - $9.66 $2,355 - $3,091
320 Added 1.37%
23,613 $175,000
Q2 2024

Jul 31, 2024

BUY
$7.31 - $10.9 $92,106 - $137,340
12,600 Added 117.83%
23,293 $187,000
Q1 2024

Apr 29, 2024

BUY
$8.13 - $13.77 $1,544 - $2,616
190 Added 1.81%
10,693 $124,000
Q4 2023

Feb 06, 2024

BUY
$6.66 - $16.03 $69,949 - $168,363
10,503 New
10,503 $117,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $463M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.